BioPorto A/S: BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029
Announcement no. 05BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 Copenhagen, Denmark, March 19, 2025, (GLOBE NEWSWIRE) - BioPorto A/S (BioPorto or Company) ...
BioPorto A/S: BioPorto announces the Annual Report for 2024
Announcement no. 06BioPorto announces the Annual Report for 2024 Copenhagen, Denmark, March 20, 2025, (GLOBE NEWSWIRE) - BioPorto A/S (BioPorto or company) (CPH:BIOPOR), an in vitro diagnostics ...
thorax.bmj21d
Effects of written action plan adherence on COPD exacerbation recovery
2 Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre, Montréal, Canada 3 Department of Epidemiology, Biostatistics and Occupational Health, ...
morningstar.com.au2y
Bioporto AS
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio ...